XML 13 R2.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS - UNAUDITED - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Net sales $ 113,777 $ 115,651 $ 301,049 $ 353,959
Cost of goods sold 76,871 78,594 204,677 235,084
Gross Margin 36,906 37,057 96,372 118,875
Selling, general and administrative expenses 16,883 17,774 48,310 52,371
Research and development expenses 5,723 6,806 18,653 19,854
Restructuring charges 1,041 2,342 1,416 5,337
Loss (gain) on sale of assets 0 11 0 (111)
Operating earnings 13,259 10,124 27,993 41,424
Other (expense) income:        
Interest expense (857) (812) (2,617) (1,745)
Interest income 217 524 852 1,396
Other income (expense), net 1,617 (2,636) (109) (3,646)
Total other income (expense), net 977 (2,924) (1,874) (3,995)
Earnings before income taxes 14,236 7,200 26,119 37,429
Income tax expense 3,163 4,478 6,381 11,345
Net earnings $ 11,073 $ 2,722 $ 19,738 $ 26,084
Earnings per share:        
Basic $ 0.34 $ 0.08 $ 0.61 $ 0.80
Diluted $ 0.34 $ 0.08 $ 0.61 $ 0.79
Basic weighted – average common shares outstanding: 32,268 32,642 32,331 32,748
Effect of dilutive securities 241 425 270 417
Diluted weighted – average common shares outstanding: 32,509 33,067 32,601 33,165
Cash dividends declared per share $ 0.04 $ 0.04 $ 0.12 $ 0.12